RecruitingNCT06248580

Find HDV and Determine Its Status in Turkey

Find HDV and Determine Its Status in Turkey "SITU(HD)VATION"


Sponsor

Yaşar Bayındır, MD

Enrollment

20,000 participants

Start Date

Mar 11, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • Adults (Age≥18)
  • Being HBsAg positive for at least six months
  • Being a citizen of the Republic of Türkiye

Interventions

DIAGNOSTIC_TESTAnti Delta

Anti Delta by ELISA


Locations(2)

Guven Hospital

Ankara, Turkey (Türkiye)

Dicle University, Faculty of Medicine

Diyarbakır, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06248580


Related Trials